NLM Logo

MP regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
MP regimen
Unique ID
C065095
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C065095
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Methotrexate
Frequency
7
Note
chemotherapy protocol consisting of above cpds; used in the treatment of advanced bladder cancer; do not confuse with MP protocol (melphalan & prednisone) nor with MP combination (melphalan & prednisolone)
Source
Arch Ital Urol Nefrol Androl 1990;62(2):243
Date of Entry
1990/08/29
Revision Date
2000/11/30
MP regimen Preferred
page delivered in 0.004s